ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

COG Cambridge Cognition Holdings Plc

56.20
1.20 (2.18%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cambridge Cognition Holdings Plc LSE:COG London Ordinary Share GB00B8DV9647 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.20 2.18% 56.20 54.00 55.00 54.50 54.50 54.50 21,504 16:35:07
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 12.61M -409k -0.0117 -46.58 18.99M

Cambridge Cognition Holdings PLC Notice of Results (0762I)

25/08/2016 7:02am

UK Regulatory


Cambridge Cognition (LSE:COG)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Cambridge Cognition Charts.

TIDMCOG

RNS Number : 0762I

Cambridge Cognition Holdings PLC

25 August 2016

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Notice of Results

The neuroscience company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG), which develops and markets near patient technologies for the assessment of brain health to improve the drug development process, will be reporting its interim results for the six months ended 30 June 2016 on Thursday 22 September 2016.

Enquiries:

 
 Cambridge Cognition             www.cambridgecognition.com 
  Holdings plc 
 Steven Powell, Chief                    Tel: 01223 810 700 
  Executive Officer 
 Nick Walters, Chief 
  Financial Officer 
 
 finnCap Ltd (Nomad                      Tel: 020 7220 0500 
  and Joint Broker) 
 Geoff Nash/Simon Hicks                 (Corporate Finance) 
 Alice Lane                             (Corporate Broking) 
 
 Hybridan LLP (Joint                     Tel: 020 3764 2341 
  Broker) 
 Claire Noyce                           (Corporate Broking) 
 
 

About Cambridge Cognition

Cambridge Cognition is an international neuroscience company which develops and markets near patient cognitive assessment products to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders.

For over 30 years the company's patented technology has advanced the assessment of cognition to accelerate the development of safe and effective treatments, improve patient outcomes and monitor and manage cognitive health throughout life.

Partners include the world's leading biotechnology and pharmaceutical companies; leading academic institutions; and public-private healthcare providers.

www.cambridgecognition.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORBRGDIXBDBGLS

(END) Dow Jones Newswires

August 25, 2016 02:02 ET (06:02 GMT)

1 Year Cambridge Cognition Chart

1 Year Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

Your Recent History

Delayed Upgrade Clock